Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 166

1.

Heterogenous loss of mismatch repair (MMR) protein expression: a challenge for immunohistochemical interpretation and microsatellite instability (MSI) evaluation.

McCarthy AJ, Capo-Chichi JM, Spence T, Grenier S, Stockley T, Kamel-Reid S, Serra S, Sabatini P, Chetty R.

J Pathol Clin Res. 2019 Apr;5(2):115-129. doi: 10.1002/cjp2.120. Epub 2018 Dec 19.

2.

Immunohistochemical null-phenotype for mismatch repair proteins in colonic carcinoma associated with concurrent MLH1 hypermethylation and MSH2 somatic mutations.

Wang T, Stadler ZK, Zhang L, Weiser MR, Basturk O, Hechtman JF, Vakiani E, Saltz LB, Klimstra DS, Shia J.

Fam Cancer. 2018 Apr;17(2):225-228. doi: 10.1007/s10689-017-0031-9.

3.

Immunohistochemistry for PMS2 and MSH6 alone can replace a four antibody panel for mismatch repair deficiency screening in colorectal adenocarcinoma.

Hall G, Clarkson A, Shi A, Langford E, Leung H, Eckstein RP, Gill AJ.

Pathology. 2010;42(5):409-13. doi: 10.3109/00313025.2010.493871.

PMID:
20632815
4.

Heterogenous MSH6 loss is a result of microsatellite instability within MSH6 and occurs in sporadic and hereditary colorectal and endometrial carcinomas.

Graham RP, Kerr SE, Butz ML, Thibodeau SN, Halling KC, Smyrk TC, Dina MA, Waugh VM, Rumilla KM.

Am J Surg Pathol. 2015 Oct;39(10):1370-6. doi: 10.1097/PAS.0000000000000459.

PMID:
26099011
5.

Practical guidance for mismatch repair-deficiency testing in endometrial cancer.

Stelloo E, Jansen AML, Osse EM, Nout RA, Creutzberg CL, Ruano D, Church DN, Morreau H, Smit VTHBM, van Wezel T, Bosse T.

Ann Oncol. 2017 Jan 1;28(1):96-102. doi: 10.1093/annonc/mdw542.

6.

[Expression and clinical significance of MMR protein and MLH1 promoter methylation testing in endometrial cancer].

Jin W, Wang LQ, Liu Y, Liu AJ.

Zhonghua Fu Chan Ke Za Zhi. 2018 Dec 25;53(12):823-830. doi: 10.3760/cma.j.issn.0529-567x.2018.12.005. Chinese.

PMID:
30585020
7.

Isolated loss of PMS2 expression in colorectal cancers: frequency, patient age, and familial aggregation.

Gill S, Lindor NM, Burgart LJ, Smalley R, Leontovich O, French AJ, Goldberg RM, Sargent DJ, Jass JR, Hopper JL, Jenkins MA, Young J, Barker MA, Walsh MD, Ruszkiewicz AR, Thibodeau SN.

Clin Cancer Res. 2005 Sep 15;11(18):6466-71.

8.

Neoadjuvant therapy induces loss of MSH6 expression in colorectal carcinoma.

Bao F, Panarelli NC, Rennert H, Sherr DL, Yantiss RK.

Am J Surg Pathol. 2010 Dec;34(12):1798-804. doi: 10.1097/PAS.0b013e3181f906cc.

PMID:
21107085
9.

Detection of mismatch repair gene germline mutation carrier among Chinese population with colorectal cancer.

Jin HY, Liu X, Li VK, Ding Y, Yang B, Geng J, Lai R, Ding S, Ni M, Zhao R.

BMC Cancer. 2008 Feb 7;8:44. doi: 10.1186/1471-2407-8-44.

10.

Immunohistochemistry and microsatellite instability testing for selecting MLH1, MSH2 and MSH6 mutation carriers in hereditary non-polyposis colorectal cancer.

Cald├ęs T, Godino J, Sanchez A, Corbacho C, De la Hoya M, Lopez Asenjo J, Saez C, Sanz J, Benito M, Ramon Y Cajal S, Diaz-Rubio E.

Oncol Rep. 2004 Sep;12(3):621-9.

PMID:
15289847
11.

Association of tumor morphology with mismatch-repair protein status in older endometrial cancer patients: implications for universal versus selective screening strategies for Lynch syndrome.

Rabban JT, Calkins SM, Karnezis AN, Grenert JP, Blanco A, Crawford B, Chen LM.

Am J Surg Pathol. 2014 Jun;38(6):793-800. doi: 10.1097/PAS.0000000000000177.

PMID:
24503759
12.

[Correlation between mismatch-repair protein expression and clinicopathologic features in 658 colorectal cancers].

Hu XR, Xu C, Kang Y, Wang T, Zhang Y, Yang XH.

Zhonghua Bing Li Xue Za Zhi. 2018 Nov 8;47(11):827-833. doi: 10.3760/cma.j.issn.0529-5807.2018.11.003. Chinese.

PMID:
30423605
13.

Microsatellite instability analysis and/or immunostaining for the diagnosis of hereditary nonpolyposis colorectal cancer?

Halvarsson B, Lindblom A, Rambech E, Lagerstedt K, Nilbert M.

Virchows Arch. 2004 Feb;444(2):135-41. Epub 2003 Dec 2.

PMID:
14652751
14.

The added value of PMS2 immunostaining in the diagnosis of hereditary nonpolyposis colorectal cancer.

Halvarsson B, Lindblom A, Rambech E, Lagerstedt K, Nilbert M.

Fam Cancer. 2006;5(4):353-8. Epub 2006 Jul 12.

PMID:
16817031
15.

Microsatellite instability and novel mismatch repair gene mutations in northern Chinese population with hereditary non-polyposis colorectal cancer.

Sheng JQ, Chan TL, Chan YW, Huang JS, Chen JG, Zhang MZ, Guo XL, Mu H, Chan AS, Li SR, Yuen ST, Leung SY.

Chin J Dig Dis. 2006;7(4):197-205.

PMID:
17054581
16.

Frequent CTNNB1 or PIK3CA Mutations Occurred in Endometrial Endometrioid Adenocarcinoma With High Levels of Microsatellite Instability and Loss of MSH2/MSH6 Expression.

Huang HN, Kuo CW, Lin MC, Mao TL, Kuo KT.

Appl Immunohistochem Mol Morphol. 2019 Feb 15. doi: 10.1097/PAI.0000000000000749. [Epub ahead of print]

PMID:
30789355
17.

Practical guidance for mismatch repair-deficiency testing in endometrial cancer.

Stelloo E, Jansen AML, Osse EM, Nout RA, Creutzberg CL, Ruano D, Church DN, Morreau H, Smit VTHBM, van Wezel T, Bosse T.

Ann Oncol. 2017 Jan 1;28(1):96-102. doi: 10.1093/annonc/mdw542.

PMID:
31792526
18.

Detection of DNA Mismatch Repair Protein Abnormalities in Sudanese Colorectal Cancer Patients Using Immunohistochemical Methods.

Zakout YM, Lanza G.

J Gastrointest Cancer. 2019 Sep;50(3):530-536. doi: 10.1007/s12029-018-0118-z.

PMID:
29850986
19.

[Value of detection of DNA mismatch repair proteins deficiency by immunohistochemistry in predicting tumor microsatellite status].

Qin Y, Liang L, Zheng X, Zheng J, Ye J, Guo L, Zhao F, Shi X.

Zhonghua Bing Li Xue Za Zhi. 2015 Oct;44(10):704-8. Chinese.

PMID:
26702526
20.

Granular dot-like staining with MLH1 immunohistochemistry is a clone-dependent artefact.

Dasgupta S, Ewing-Graham PC, Groenendijk FH, Stam O, Biermann KE, Doukas M, Dubbink HJ, van Velthuysen MF, Dinjens WNM, Van Bockstal MR.

Pathol Res Pract. 2020 Jan;216(1):152581. doi: 10.1016/j.prp.2019.152581. Epub 2019 Aug 5.

PMID:
31402167

Supplemental Content

Support Center